The Lancet18d
TACE plus immune checkpoint inhibitor-based systemic therapies for hepatocellular carcinoma
Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cancer Research27d
Treatment and Survival Differences between Patients with Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma of the Breast
1Department of Medical Oncology, Montefiore Einstein Comprehensive Cancer Center, Bronx, New York. *Corresponding Author: Jesus D. Anampa, Montefiore Einstein Comprehensive Cancer Center, 1695 ...
The Canary29d
Invasive lobular carcinoma: a silent killer the Labour government is failing to act upon
Invasive lobular carcinoma (ILC) is the second most common type of breast cancer, representing up to 15% of all breast cancers cases, and is the sixth most prevalent cancer among women.